Way-100,635

Way-100,635

SCHEMBL4077975

COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Way-100,635. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 2/20 1.00
KMT2A known ✓ Q03164 2/20 1.00
HTR1A known ✓ P08908 9/20 0.90
ADRA1A known ✓ P35348 5/20 0.90
ADRA1B known ✓ P35368 4/20 0.90
ADRA1D known ✓ P25100 3/20 0.90
HTR2B known ✓ P41595 2/20 0.89
HTR2A known ✓ P28223 1/20 0.68
SMN1; SMN2 Q16637 2/20 1.00
LMNA P02545 1/20 1.00
BLM P54132 1/20 1.00
PMP22 Q01453 1/20 1.00
DRD4 P21917 4/20 0.90
HTR7 P34969 2/20 0.90
CYP3A4 P08684 2/20 0.90
CYP2D6 P10635 2/20 0.90
TSHR P16473 1/20 0.90
HTR1B P28222 1/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Way-100,635 SCHEMBL29519870 1.00 SMN1; SMN2 (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL4077972 1.00 SMN1; SMN2 (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL30366505 1.00 SMN1; SMN2 (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL84178 0.95 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL30720034 0.95 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL29451114 0.95 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL13398069 0.95 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL29486911 0.94 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL194436 0.94 HTR1A (0.98) SMN1; SMN2MEN1KMT2ALMNABLM
Way-100,635 SCHEMBL6064589 0.94 HTR1A (1.00) SMN1; SMN2MEN1KMT2ALMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090556-A2 ARTIFICIAL REPRODUCTION OF PHARMACEUTICAL CONDITIONS OF DEPENDENCY TO TOBACCO AND OTHER ADDICTIVE DRUGS (OPIACEA, PSYCHOSTIMULANTS, ALCOHOL) BY COMBINATION OF NICOTINE AND A LIGAND (AGONIST OR 5 ANTAGONIST) OF 5-HT1A RECEPTORS TASSIN, THOMAS (FR) 2009-07-23 WO claimed
WO-2009090556-A2 ARTIFICIAL REPRODUCTION OF PHARMACEUTICAL CONDITIONS OF DEPENDENCY TO TOBACCO AND OTHER ADDICTIVE DRUGS (OPIACEA, PSYCHOSTIMULANTS, ALCOHOL) BY COMBINATION OF NICOTINE AND A LIGAND (AGONIST OR 5 ANTAGONIST) OF 5-HT1A RECEPTORS TASSIN, THOMAS (FR) 2009-07-23 WO disclosed